#Regeneron CEO says Trump’s use of drug cocktail puts it in ‘tough’ spot
“#Regeneron CEO says Trump’s use of drug cocktail puts it in ‘tough’ spot” Regeneron’s stock surged on the news that President Trump was treated for COVID-19 with its drug cocktail, but the company’s CEO said its high-profile patient put it in “a very tough situation.” Dr. Leonard Schleifer told CNBC on Monday that the president’s…